目的:观察右美托咪定辅助颈椎手术静脉全麻时丙泊酚用量和对术中血压、心率的影响。方法:选择40例行颈椎手术的颈椎受限患者,随机分成右美托咪定+丙泊酚+瑞芬太尼组( D组,n=20)和生理盐水+丙泊酚+瑞芬太尼组( N组,n=20)。 D组于诱导前10 min静脉泵注右美托咪啶1μg/kg,N组静脉泵注相同容量的生理盐水。术中以瑞芬太尼(血浆浓度,4 ng/mL)和丙泊酚(血浆浓度,据术中血压调节)靶控输注维持麻醉。结果:丙泊酚用量D组、N组分别为(1422.75±180.72)mg和(1902.50±151.64)mg,D组明显减少(P〈0.01);瑞芬太尼用量D组、N组分别为(2617.60±144.68)μg和(2642.25±63.37)μg,两组无明显差异(P〉0.05)。术中最低MAP、切皮时、术中最低及术中最高HR,D组明显较低(P<0.05)。组内术前、切皮时和术中最高指标比较,两组MAP均无明显差异( P〉0.05),D组术前HR高于切皮时和最高HR,后两者间无明显差异。 N组最高HR大于术前、切皮时HR(P〈0.05),后两者间无明显差异(P〉0.05)。结论:右美托咪啶辅助颈椎手术静脉全麻显著减少丙泊酚用量,是有效、安全的静脉全麻的辅助用药。
Objective: To investigate the effect of propofol consumption with the adjuvant of dexmedetomidine to intraoperative blood pressure and heart rate in patients undergoing cervical operations with total intravenous anesthesia. Methods: 40 patients accepted cervical operations were randomly allocated in two groups:Dexmedetomidine+propofol+remifentanil group ( group D, n= 20 ) , and normal saline+propofol+remifentanil group (group N, n=20). 1.0μg/kg Dexmedetomidine was administered in group D 10 minutes before the induction. Meanwhile the same volume of normal saline was administered in group N. Anesthesia was maintained by a target-controlled infusion ( TCI) of remifentanil ( plasma concentration, 4 ng/mL) and propofol ( plasma concentration, infusion rate regulated by intraoperative blood pressure) . Results:Propofol consumption was significantly less in group D than in group N (1422.75±180.72 vs. 1902.50±151.64;P〈0.01). There was no significant difference of remifentanil consumption between the two groups (2617.60±144.6 vs. 2642.25±63.37;P〉0.05). The minimal MAP, incision HR, intraoperative minimal and maximum HR in group D was significantly less (P〈0.05). Comparing the maximum HR of preoperation, incision and intraoperation in intra-group, there was no significant difference between the two groups in MAPs ( P〉0.05) . And pre-operative HR was higher than incision and maximum HR in group D, and there was no significant difference between the latter two indicators. The maximum HR was higher than pre-operative and incision HR in group N ( P〈0. 05 ) , and there was no significant difference between the latter two indicators(P〉0.05). Conclusion: Dexmedetomidine as an adjuvant can significantly reduce Propofol consumption in total intravenous anesthesia ( TIVA) of cervical operations, which is an effective and safe adjunct to TIVA.